[HTML][HTML] The new UK SARS-CoV-2 variant and lockdown–causes and consequences

D Pan, NL Mudalige, S Sze, D Koeckerling… - Clinical …, 2021 - ncbi.nlm.nih.gov
The new variant of concern (VOC), B. 1.1. 7, has a distinct set of mutations in nucleotides
encoding the spike (S) protein on the surface of SARS-CoV-2. SARS-CoV-2 previously …

The UK's speedy COVID-19 vaccine rollout: surprise success or planned perfection?

S Schiffling, L Breen - The Conversation, 2021 - researchonline.ljmu.ac.uk
The UK’s speedy COVID-19 vaccine rollout: surprise success or planned perfection? |
LJMU Research Online Skip to content Skip to menu Study Study Undergraduate students …

Planning for the emergence of vaccine-resistant SARS-CoV-2: addressing revaccination delivery bottlenecks

J Willan, K Jeffery, L Kemper, R Scott… - Journal of the Royal …, 2021 - journals.sagepub.com
As SARS-CoV-2 infection has spread in populations around the world, the original genetic
code has acquired significant heterogeneity, with the emergence of multiple variants of …

The potential risks of delaying the second vaccine dose during the SARS-CoV-2 pandemic

IR Humphreys, AJ Godkin - QJM: An International Journal of …, 2021 - academic.oup.com
Prevention of infectious diseases through vaccination is one of the greatest success stories
of medicine, with a 200 year old history. Although vaccinology is a branch of the science of …

Covid-19: Booster dose will be needed in autumn to avoid winter surge, says government adviser

E Mahase - 2021 - bmj.com
A covid-19 booster vaccine is likely to be rolled out in the autumn to avoid another winter
surge, the deputy chair of the government's vaccine advisory committee has told The …

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

G Amirthalingam, JL Bernal, NJ Andrews… - Nature …, 2022 - ncbi.nlm.nih.gov
The original version of this Article contained an error in Fig. 4, in which the titles for each
section were incorrectly shifted to the left rather than being placed above the corresponding …

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection

SSA Karim - The Lancet, 2021 - thelancet.com
Immune-escape variants have raised concerns about the effectiveness of vaccines as the
world scales up SARS-CoV-2 immunisation. COVID-19 vaccines have shown up to 95 …

[HTML][HTML] COVID-19 vaccines in 2023

K Sharma, J Li-Kim-Moy - Australian Prescriber, 2023 - ncbi.nlm.nih.gov
COVID-19 vaccines in 2023 - PMC Back to Top Skip to main content NIH NLM Logo Access
keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text …

Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden

P Nordström, M Ballin, A Nordström - The Lancet, 2022 - thelancet.com
Background Vaccine effectiveness against COVID-19 beyond 6 months remains
incompletely understood. We aimed to investigate the effectiveness of COVID-19 …

[HTML][HTML] Vaccine efficacy against severe COVID-19 in relation to delta variant (B. 1.617. 2) and time since second dose in patients in Scotland (REACT-SCOT): a case …

PM McKeigue, DA McAllister, SJ Hutchinson… - The Lancet …, 2022 - thelancet.com
Background Reports have suggested that the efficacy of vaccines against COVID-19 might
have fallen since the delta (B. 1.617. 2) SARS-CoV-2 variant replaced the alpha (B. 1.1. 7) …